INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

10943	Companies
239175	Keywords
168020	Articles
128597	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 07/02/2025 at 22:00, 1 year 2 months ago

Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits

Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
PRESS RELEASE

published on 07/02/2025 at 22:00, 1 year 2 months ago

Inventiva annonce la publication dans le Journal of Hepatology Reports des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH et dans des modèles précliniques de la maladie
Inventiva annonce la publication des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH. Des effets bénéfiques allant au-delà de l'inversion de la capillarisation ont été observés

Inventiva MASH MASLD Lanifibranor Cellules Endothéliales
BRIEF

published on 06/10/2025 at 22:05, 1 year 2 months ago

Renée Aguiar-Lucander Joins Inventiva's Board of Directors

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF

published on 06/10/2025 at 22:05, 1 year 2 months ago

Renée Aguiar-Lucander rejoint le conseil d'administration d'Inventiva

Conseil D'administration Biopharmaceutique Inventiva Lanifibranor Renée Aguiar-Lucander
PRESS RELEASE

published on 06/10/2025 at 22:00, 1 year 2 months ago

Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors
Inventiva appoints Renée Aguiar-Lucander to its Board of Directors. Aguiar-Lucander brings extensive industry experience and leadership to the company

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF

published on 05/27/2025 at 22:05, 1 year 3 months ago

Inventiva aux Conférences Jefferies et UBS sur la Santé

Biopharmaceutique Inventiva Conférence Jefferies MASH Conférence UBS
BRIEF

published on 05/27/2025 at 22:05, 1 year 3 months ago

Inventiva at the Jefferies and UBS Healthcare Conferences

Biopharmaceuticals Inventiva MASH UBS Conference Jefferies Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 1 year 3 months ago

Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
Inventiva participera à deux conférences investisseurs en juin 2025 : Jefferies Global Healthcare Conference et UBS Spring Biotech Conference. Présentation stratégique de la société et du médicament Lanifibranor

Conférences Investisseurs Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 1 year 3 months ago

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City

Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF

published on 05/23/2025 at 08:35, 1 year 3 months ago

Inventiva Reports First Quarter 2025 Financials: Cash Position Declines

Financial Results Cash Position Clinical Trial Inventiva Lanifibranor

Accesswire

Published on 09/08/2026 at 12:00, just now

Blue Lagoon to Start Drilling at Its Dome Mountain Gold Project
Published on 09/08/2026 at 09:05, 2 hours 55 minutes ago

Battery X Metals to Appoint Accomplished Technology and Consumer Brands Executive Nicholas Reichenbach to Board of Directors
Published on 09/08/2026 at 09:05, 2 hours 55 minutes ago

BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study
Published on 09/08/2026 at 09:01, 2 hours 59 minutes ago

Apex Expands Trinity Zone with Step-out Hole Returning 197.5 m Interval of 2.12% REO at the Rift Rare Earth Project in SE Nebraska
Published on 09/08/2026 at 01:45, 10 hours 15 minutes ago

Tunkillia Environmental Scoping Report Approved

View all ACCESSWIRE

EQS Group

Published on 09/08/2026 at 11:52, 8 minutes ago

Turkiye Garanti Bankasi A.S.: Board Of Directors Decision About Garanti Bank Intermediary Institution Warrant and Authorization of Head Office for Necessary Operations
Published on 09/08/2026 at 11:45, 15 minutes ago

Nexum Group Expands Capacity to Deliver Residential Real Estate Projects — Rainer Kunze Appointed as Technical Project Lead
Published on 09/08/2026 at 11:08, 51 minutes ago

DB remains committed to High Speed Grinding
Published on 09/08/2026 at 11:07, 53 minutes ago

SBF expand industrial and commercial lighting business through partnership with CONLED
Published on 09/08/2026 at 11:01, 58 minutes ago

CHAPTERS Group AG Raises 2026 Outlook for Organic Growth and Reports Preliminary Results for the First Half of 2026

Les Echos

Published on 09/08/2026 at 11:00, 1 hour ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 1 hour ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 09/08/2026 at 10:21, 1 hour 39 minutes ago

Disclosure of Share Capital and Voting Rights as of August 31, 2026
Published on 09/08/2026 at 10:21, 1 hour 39 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 août 2026
Published on 09/08/2026 at 08:30, 3 hours 30 minutes ago

Klarsen : calendrier de communication

View all LES ECHOS COMFI WIRE